131I 治疗甲亢后继发分化型甲状腺癌——病例报告

Differentiated thyroid cancer following radioiodide 131I therapy of hyperthyroidism--a case report.

作者信息

Nĕmec J, Soumar J, Zeman V, Nahodil V, Zamrazil V, Smejkal V

出版信息

Oncology. 1978;35(6):277-80. doi: 10.1159/000225305.

Abstract

Differentiated (papillary) thyroid cancer was detected 17 years following radioiodide 131I treatment for toxic multinodular goiter. 21 cases of thyroid cancers with previous 131 I therapy for hyperthyroidism were summarised. This combination is rare compared to the incidence of thyroid cancers following external irradiation. This may be due to higher absorbed dose to thyroid in 131I treatment.

摘要

分化型（乳头状）甲状腺癌在放射性碘131I治疗毒性多结节性甲状腺肿17年后被发现。总结了21例曾接受131I治疗甲亢的甲状腺癌病例。与外照射后甲状腺癌的发病率相比，这种情况较为罕见。这可能是由于131I治疗中甲状腺吸收剂量较高所致。